![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/06/07/2895248/0/en/Zealand-Pharma-announces-that-Boehringer-Ingelheim-s-survodutide-demonstrates-breakthrough-improvement-in-liver-fibrosis-with-no-worsening-of-MASH-in-64-5-of-patients-with-F2-and-F.html
https://www.globenewswire.com/news-release/2024/06/07/2895231/0/en/Boehringer-Ingelheim-s-survodutide-shows-breakthrough-improvement-in-liver-fibrosis-with-no-worsening-of-MASH-in-64-5-of-patients-with-F2-and-F3-fibrosis.html
https://www.globenewswire.com/news-release/2024/06/06/2894525/0/en/Zealand-Pharma-announces-that-Boehringer-Ingelheim-will-present-positive-results-from-Phase-2-trial-with-survodutide-in-MASH-at-EASL.html
https://www.biopharmadive.com/news/boehringer-zealand-mash-nash-obesity-drug-results/708475/#:~:text=Summary%20results%20disclosed%20Monday%20show,18%25%20of%20those%20given%20placebo.